Microbial Ageing and Longevity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Senescence Can Explain Microbial Persistence
Senescence Can Explain Microbial Persistence I. Klappera,b, P. Gilbertc, B.P. Ayatid, J. Dockerya,b, P.S. Stewartb,e aDepartment of Mathematical Sciences, Montana State University, Bozeman, MT 59717 bCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717 cSchool of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manch- ester, UK dDepartment of Mathematics, Southern Methodist University, Dallas, TX 75205 eDepartment of Chemical and Biological Engineering, Montana State University, Bozeman, MT 59717. Corresponding author: Isaac Klapper, Department of Mathematical Sciences, Mon- tana State University, Bozeman, MT 59717. Tel. (406)-994-5231. Fax. (406)-994- 1789. email: [email protected]. Running Title: Senescence Can Explain Microbial Persistence Contents Category: Theoretical Microbiology 1 Summary. It has been known for many years that small fractions of persister cells re- sist killing in many bacterial colony-antimicrobial confrontations. These persisters are not believed to be mutants. Rather it has been hypothesized that they are phenotypic variants. Current models allow cells to switch in and out of the persister phenotype. Here a different explanation is suggested, namely senescence, for persistence. Using a mathematical model including age structure, it is shown that senescence provides a natural explanation for persistence-related phenomena including the observations that persister fraction depends on growth phase in batch culture and dilution rate in continuous culture. 1 Introduction It has been observed (Balaban et al., 2004; Bigger, 1944; Gilbert et al., 1990; Green- wood & O’Grady, 1970; Keren et al., 2004B; McDermott, 1958; Moyed & Bertrand, 1983; Sufya et al., 2003; Harrison et al., 2005; Wiuff et al., 2005), dating to Bigger (1944), that many antimicrobials while effective in reducing bacterial populations are unable to eliminate them entirely, even with prolonged exposure. -
Gene Therapy Glossary of Terms
GENE THERAPY GLOSSARY OF TERMS A • Phase 3: A phase of research to describe clinical trials • Allele: one of two or more alternative forms of a gene that that gather more information about a drug’s safety and arise by mutation and are found at the same place on a effectiveness by studying different populations and chromosome. different dosages and by using the drug in combination • Adeno-Associated Virus: A single stranded DNA virus that has with other drugs. These studies typically involve more not been found to cause disease in humans. This type of virus participants.7 is the most frequently used in gene therapy.1 • Phase 4: A phase of research to describe clinical trials • Adenovirus: A member of a family of viruses that can cause occurring after FDA has approved a drug for marketing. infections in the respiratory tract, eye, and gastrointestinal They include post market requirement and commitment tract. studies that are required of or agreed to by the study • Adeno-Associated Virus Vector: Adeno viruses used as sponsor. These trials gather additional information about a vehicles for genes, whose core genetic material has been drug’s safety, efficacy, or optimal use.8 removed and replaced by the FVIII- or FIX-gene • Codon: a sequence of three nucleotides in DNA or RNA • Amino Acids: building block of a protein that gives instructions to add a specific amino acid to an • Antibody: a protein produced by immune cells called B-cells elongating protein in response to a foreign molecule; acts by binding to the • CRISPR: a family of DNA sequences that can be cleaved by molecule and often making it inactive or targeting it for specific enzymes, and therefore serve as a guide to cut out destruction and insert genes. -
Human Germline Genome Editing: Fact Sheet
Human germline genome editing: fact sheet Purpose • To contribute to evidence-informed discussions about human germline genome editing. KEY TAKEAWAYS • Gene editing offers the potential to improve human health in ways not previously possible. • Making changes to human genes that can be passed on to future generations is prohibited in Australia. • Unresolved questions remain on the possible long-term impacts, unintended consequences, and ethical issues associated with introducing heritable changes by editing of the genome of human gametes (sperm and eggs) and embryos. • AusBiotech believes the focus of human gene editing should remain on non-inheritable changes until such time as the scientific evidence, regulatory frameworks and health care models have progressed sufficiently to warrant consideration of any heritable genetic edits. Gene editing Gene editing is the insertion, deletion, or modification of DNA to modify an organism’s specific genetic characteristics. New and evolving gene editing techniques and tools (e.g. CRISPR) allow editing of genes with a level of precision that increases its applications across the health, agricultural, and industrial sectors. These breakthrough techniques potentially offer a range of different options for treating devastating human diseases and delivering environmentally sustainable food production systems that can feed the world’s growing population, which is expected to exceed nine billion by 2050. The current primary application of human gene editing is on non-reproductive cells (‘somatic’ cells) -
The Male Germline-Specific Protein MAPS Is Indispensable for Pachynema Progression and Fertility
The male germline-specific protein MAPS is indispensable for pachynema progression and fertility Miao Lia,b, Jiahuan Zhenga,b, Gaopeng Lic, Zexiong Lina, Dongliang Lia, Dongteng Liua,b, Haiwei Fenga,b, Dandan Caoa, Ernest H. Y. Nga,b, Raymond H. W. Lia,b, Chunsheng Hand,e,f, William S. B. Yeunga,b, Louise T. Chowc,1, Hengbin Wangc,1, and Kui Liua,b,1 aShenzhen Key Laboratory of Fertility Regulation, Center of Assisted Reproduction and Embryology, The University of Hong Kong–Shenzhen Hospital, 518053 Shenzhen, Guangdong, China; bDepartment of Obstetrics and Gynecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; cDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0024; dState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 100101 Beijing, China; eInstitute for Stem Cell and Regeneration, Chinese Academy of Sciences, 100101 Beijing, China; and fUniversity of Chinese Academy of Sciences, Chinese Academy of Sciences, 100049 Beijing, China Contributed by Louise T. Chow, January 12, 2021 (sent for review December 10, 2020; reviewed by Anders Hofer, Kazuhiro Kawamura, and Mingxi Liu) Meiosis is a specialized cell division that creates haploid germ cells to transient transcriptional silencing in a process termed meiotic from diploid progenitors. Through differential RNA expression sex chromosome inactivation (MSCI) (6, 7). analyses, we previously identified a number of mouse genes that Over the past decades, the underlying molecular aspects of were dramatically elevated in spermatocytes, relative to their very meiosis prophase I have been widely studied. Various mutant low expression in spermatogonia and somatic organs. -
Guide to Interpreting Genomic Reports: a Genomics Toolkit
Guide to Interpreting Genomic Reports: A Genomics Toolkit A guide to genomic test results for non-genetics providers Created by the Practitioner Education Working Group of the Clinical Sequencing Exploratory Research (CSER) Consortium Genomic Report Toolkit Authors Kelly East, MS, CGC, Wendy Chung MD, PhD, Kate Foreman, MS, CGC, Mari Gilmore, MS, CGC, Michele Gornick, PhD, Lucia Hindorff, PhD, Tia Kauffman, MPH, Donna Messersmith , PhD, Cindy Prows, MSN, APRN, CNS, Elena Stoffel, MD, Joon-Ho Yu, MPh, PhD and Sharon Plon, MD, PhD About this resource This resource was created by a team of genomic testing experts. It is designed to help non-geneticist healthcare providers to understand genomic medicine and genome sequencing. The CSER Consortium1 is an NIH-funded group exploring genomic testing in clinical settings. Acknowledgements This work was conducted as part of the Clinical Sequencing Exploratory Research (CSER) Consortium, grants U01 HG006485, U01 HG006485, U01 HG006546, U01 HG006492, UM1 HG007301, UM1 HG007292, UM1 HG006508, U01 HG006487, U01 HG006507, R01 HG006618, and U01 HG007307. Special thanks to Alexandria Wyatt and Hugo O’Campo for graphic design and layout, Jill Pope for technical editing, and the entire CSER Practitioner Education Working Group for their time, energy, and support in developing this resource. Contents 1 Introduction and Overview ................................................................ 3 2 Diagnostic Results Related to Patient Symptoms: Pathogenic and Likely Pathogenic Variants . 8 3 Uncertain Results -
Biology of the Caenorhabditis Elegans Germline Stem Cell System
| WORMBOOK CELL FATE, SIGNALING, AND DEVELOPMENT Biology of the Caenorhabditis elegans Germline Stem Cell System E. Jane Albert Hubbard*,1 and Tim Schedl†,1 *Skirball Institute of Biomolecular Medicine, Departments of Cell Biology and Pathology, New York University School of Medicine, † New York 10016 and Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 ORCID IDs: 0000-0001-5893-7232 (E.J.A.H.); 0000-0003-2148-2996 (T.S.) ABSTRACT Stem cell systems regulate tissue development and maintenance. The germline stem cell system is essential for animal reproduction, controlling both the timing and number of progeny through its influence on gamete production. In this review, we first draw general comparisons to stem cell systems in other organisms, and then present our current understanding of the germline stem cell system in Caenorhabditis elegans. In contrast to stereotypic somatic development and cell number stasis of adult somatic cells in C. elegans, the germline stem cell system has a variable division pattern, and the system differs between larval development, early adult peak reproduction and age-related decline. We discuss the cell and developmental biology of the stem cell system and the Notch regulated genetic network that controls the key decision between the stem cell fate and meiotic development, as it occurs under optimal laboratory conditions in adult and larval stages. We then discuss alterations of the stem cell system in response to environ- mental perturbations and aging. A recurring distinction is between processes that control stem cell fate and those that control cell cycle regulation. C. elegans is a powerful model for understanding germline stem cells and stem cell biology. -
Glossary of Genes & Syndromes-Feighanne Hathaway
Glossary of Genes & Syndromes Feighanne Hathaway, MS LCGC Licensed Certified Genetic Counselor University Of Chicago Disclosures ▪ None 2 What is Cancer Genetics 3 The Precision Medicine Initiative ▪ Disease treatment and prevention that incorporates individual genetic variation, environment and lifestyle ▪ Expand efforts in cancer genomics ▪ Support trials testing combinations of targeted therapies based on tumor’s molecular signature 4 Precision Medicine What is the best Why did I get this treatment for MY cancer? cancer? What is my chance to get What is the best cancer? screening for my risk? What is the Am I at risk for prognosis of MY severe side cancer? effects from this treatment? Precision Medicine Risk Pharmacogenomics New Therapies prediction • Drug dose of • Genetic defect • Begin colonoscopy medication at age 40 targeted therapy determined by for specific • Avoid high fat in drug metabolism disease diet genetic profile 6 All Cancer is Genetic Genetics Terminology ▪ Type of genetic testing Germline Somatic ▪ Possible genetic testing results Positive Negative Variant of uncertain significance ▪ Different Genes = Different Risks 8 Somatic vs Germline • Germline mutations = • germ cells (egg + sperm) • inherited • present from conception • present in every cell of the body • can be passed on to future generations • Somatic mutations = • Acquired • Arise by chance in any cell of the body • Cannot be passed down 9 Germline (inherited) vs. Tumor (somatic) Genetics Sporadic Cancer Hereditary Cancer 10 Genetics Terminology Nucleotide: -
Sample Thesis Title with a Concise and Accurate Description
ELUCIDATION OF NOVEL PHYSIOLOGICAL AND GENETIC ELEMENTS ASSOCIATED WITH THE COLD ADAPTABILITY AND SURVIVAL OF LISTERIA MONOCYTOGENES IN THE FOOD PROCESSING CONTINUUM by Patricia Hingston B.A.Sc., Dalhousie University, 2010 M.Sc. Dalhousie University, 2013 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Food Science) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) December 2017 © Patricia Hingston, 2017 i Abstract Novel physiological and genetic factors associated with the survival of Listeria monocytogenes in the food-processing continuum were investigated, with an emphasis on its cold- growth ability. Food-related L. monocytogenes strains (n=166) were sequenced and subsequently evaluated on their ability to tolerate cold (4°C), salt (6% NaCl, 25°C), acid (pH 5, 25°C), and desiccation (33% RH, 20°C) stress. Stress tolerances were associated with serotype, clonal complex, full-length inlA profiles, and plasmid harbourage. Notably, strains possessing full length inlA (as opposed to a truncated version) exhibited significantly (p<0.001) enhanced cold tolerance and plasmid-positive strains demonstrated enhanced (p=0.013) acid tolerance. Relative gene expression indicated that several plasmid-encoded genes (e.g., NADH peroxidase, clpL, proW) are induced in L. monocytogenes during growth in 6% NaCl and at pH 5. Additionally, a whole- genome sequence phylogeny revealed closely related stress sensitive and tolerant strains, highlighting that minor genetic differences impact strain phenotypes. Strand-specific RNA sequencing showed that L. monocytogenes suppresses 1.3× more genes than it induces at 4°C relative to 20°C. The largest number (n=1,431) and greatest magnitude (>1,000-fold) of differentially expressed (e.g., >2-fold, p<0.05) genes occurred in late stationary- phase cells. -
Small Rnas in Germline Development
CHAPTER SIX Small RNAs in Germline Development Matthew S. Cook*,†,‡,1, Robert Blelloch*,†,‡ * Department of Urology, University of California, San Francisco, California, USA †Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, California, USA ‡Center for Reproductive Sciences, University of California, San Francisco, California, USA 1Corresponding author: e-mail address: [email protected] Contents 1. Introduction: Germline Development and Small Regulatory RNAs 160 1.1 Germ cell life cycle and posttranscriptional regulation of gene expression 160 1.2 Small RNAs 167 2. Small RNAs in Germ Cells 172 2.1 Small RNAs in PGC specification and migration 177 2.2 Small RNAs in PGC gonad colonization and early differentiation 180 2.3 Small RNAs in spermatogenesis 183 2.4 Small RNAs in oogenesis 186 3. Small RNAs in Germ Cell Tumor Formation 189 3.1 miRNAs, siRNAs, and piRNAs in GCTs 190 4. Conclusion 191 Acknowledgments 192 References 192 Abstract One of the most important and evolutionarily conserved strategies to control gene expression in higher metazoa is posttranscriptional regulation via small regulatory RNAs such as microRNAs (miRNAs), endogenous small interfering RNAs (endo-siRNAs), and piwi-interacting RNAs (piRNAs). Primordial germ cells, which are defined by their toti- potent potential and noted for their dependence on posttranscriptional regulation by RNA-binding proteins, rely on these small regulatory RNAs for virtually every aspect of their development, including specification, migration, and differentiation into com- petent gametes. Here, we review current knowledge of the roles miRNAs, endo-siRNAs, and piRNAs play at all stages of germline development in various organisms, focusing on studies in the mouse. -
Germ Cells, Origin of Somatic Stem Cells?
Cell Research (2008) 18:s26. npg © 2008 IBCB, SIBS, CAS All rights reserved 1001-0602/08 $ 30.00 www.nature.com/cr Concurrent Session 2 Germ cells, origin of somatic stem cells? Karim Nayernia1 1 North East Institute of Stem Cell Biology, Institute of Human genetics, International Centre for Life, Central Parkway, University of Newcastle upon Tyne, UK Germ cells are highly specialized cells that form gametes, and they are the only cells within an organism that contribute genes to offspring. Germline stem cells (GSCs) sustain gamete production, both oogenesis (egg production) and spermatogenesis (sperm production), in many organisms. Since the genetic information contained within germ cells is passed from generation to generation, the germ line is often referred to as immortal. Therefore, it is possible that germ cells possess unique strategies to protect and transmit the genetic information contained within them indefinitely. On the other hand, it was shown that germ cells are pluripotent in all stages of development. We and other groups succeeded in the long-term culture of spermatogonial stem cells (SSCs) of mice. The cells were phenotypically similar to the ES/embryonic germ cells except for their genomic imprinting pattern. They differentiated into various types of somatic cells in vitro under the conditions used to induce the differentiation of the ES cells, and the SSCs formed germline chimeras when injected into blastocysts. Furthermore, we have shown that somatic stem cells are able to differentiate to germ cells. Derivation of both male and female gametes in vitro raises the possibility of using these gametes to gain a better understanding of basic reproductive biology and, in particular, to extend the potential for therapeutic cloning, transgenic technologies and the treatment of infertility. -
Senescence in Bacteria and Its Underlying Mechanisms
fcell-09-668915 June 14, 2021 Time: 13:54 # 1 REVIEW published: 18 June 2021 doi: 10.3389/fcell.2021.668915 Senescence in Bacteria and Its Underlying Mechanisms Ulrich Karl Steiner* Evolutionary Demography Group, Institute of Biology, Freie Universität Berlin, Berlin, Germany Bacteria have been thought to flee senescence by dividing into two identical daughter cells, but this notion of immortality has changed over the last two decades. Asymmetry between the resulting daughter cells after binary fission is revealed in physiological function, cell growth, and survival probabilities and is expected from theoretical understanding. Since the discovery of senescence in morphologically identical but physiologically asymmetric dividing bacteria, the mechanisms of bacteria aging have been explored across levels of biological organization. Quantitative investigations are heavily biased toward Escherichia coli and on the role of inclusion bodies—clusters of misfolded proteins. Despite intensive efforts to date, it is not evident if and how Edited by: Owen Jones, inclusion bodies, a phenotype linked to the loss of proteostasis and one of the University of Southern Denmark, consequences of a chain of reactions triggered by reactive oxygen species, contribute Denmark to senescence in bacteria. Recent findings in bacteria question that inclusion bodies Reviewed by: are only deleterious, illustrated by fitness advantages of cells holding inclusion bodies Jun Zhou, German Cancer Research Center under varying environmental conditions. The contributions of other hallmarks of aging, (DKFZ), Germany identified for metazoans, remain elusive. For instance, genomic instability appears to Stefano Pagliara, University of Exeter, United Kingdom be age independent, epigenetic alterations might be little age specific, and other Urszula Lapinska, hallmarks do not play a major role in bacteria systems. -
Two Distinct Pathways of Pregranulosa Cell Differentiation Support Follicle Formation in the Mouse Ovary
Two distinct pathways of pregranulosa cell differentiation support follicle formation in the mouse ovary Wanbao Niua,b and Allan C. Spradlinga,b,1 aHoward Hughes Medical Institute Research Laboratories, Carnegie Institution for Science, Baltimore, MD 21218; and bDepartment of Embryology, Carnegie Institution for Science, Baltimore, MD 21218 Contributed by Allan C. Spradling, July 2, 2020 (sent for review March 25, 2020; reviewed by Brigid L. M. Hogan and Melissa Pepling) We sequenced more than 52,500 single cells from embryonic day (EPG) cell population begins production at least by E14.5, also 11.5 (E11.5) postembryonic day 5 (P5) gonads and performed from progenitors in the ovarian surface epithelium (22, 23). These lineage tracing to analyze primordial follicles and wave 1 medullar cells express Lgr5 and eventually differentiate as granulosa cells follicles during mouse fetal and perinatal oogenesis. Germ cells on second wave follicles (8, 21–23). The cellular origins, division clustered into six meiotic substages, as well as dying/nurse cells. timing, and gene expression programs underlying both groups of Wnt-expressing bipotential precursors already present at E11.5 are PG cells need to be more precisely defined. Ultimately, the extent followed at each developmental stage by two groups of ovarian to which these cells control the different properties of the two pregranulosa (PG) cells. One PG group, bipotential pregranulosa follicular waves remains of interest. (BPG) cells, derives directly from bipotential precursors, expresses Evolutionary conservation provides another potentially valu- Foxl2 early, and associates with cysts throughout the ovary by able source of insight into ovarian follicle development. In both E12.5.